Video Latest - ecancer

Combining immunological and targeted agents in melanoma

Dr Axel Hoos - GlaxoSmithKline, Collegeville, USA

26 Jun 2014

Perspectives for effective cancer drug development: The EORTC SPECTA Initiative

Dr Denis Lacombe - EORTC, Brussels, Belgium

26 Jun 2014

Cancer stem cells and malignant progression

Prof Rob Weinberg - Massachusetts Institute of Technology, Cambridge, USA

26 Jun 2014

Colorectal cancer screening and the EORTC SPECTA initiative

Dr Sabine Tejpar - University of Leuven, Leuven, Belgium

26 Jun 2014

microRNA replacement in malignant pleural mesothelioma

Dr Glen Reid - The University of Sydney, Sydney, Australia

26 Jun 2014

Personalised cancer medicine using the human protein atlas and affibodies

Prof Mathias Uhlén - Royal Institute of Technology (KTH), Stockholm, Sweden

26 Jun 2014

ARC Foundation's work and aims

Dr Jacques Raynaud - Foundation ARC pour la Recherche Cancer, Villejuif, France

26 Jun 2014

IDH1 mutation in haemato-oncology

Dr Christof von Kalle - German Cancer Research Center (DKFZ), Heidelberg, Germany

26 Jun 2014

EORTC fosters move towards tailored cancer treatment through the SPECTA initiative in colorectal cancer

Prof Roger Stupp - President of the European Organization for Research and Treatment of Cancer (EORTC)

26 Jun 2014

Novel drug targets and potential combinations in childhood brain tumours

Dr Stefan Pfister - German Cancer Research Center (DKFZ), Heidelberg, Germany

26 Jun 2014

ecancermedicalscience editor's choice for June 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

24 Jun 2014

Tackling inequality in access to cancer care and information

Prof Mark Lawler - Queen's University Belfast, Belfast, UK

20 Jun 2014

Video